Adriamycin Doxorubicin 50 Mg Injection

Q1: What is Adriamycin (Doxorubicin) used for?

Adriamycin is a powerful anthracycline chemotherapy drug used to treat breast cancer, Hodgkin's and non-Hodgkin's lymphomas, acute leukemias, sarcomas, bladder, lung, ovarian, and thyroid cancers as part of combination regimens.

Q2: How does Adriamycin work against cancer?

Doxorubicin intercalates into DNA strands and inhibits the topoisomerase II enzyme, preventing DNA replication and RNA transcription in cancer cells. It also generates free radicals causing additional cellular damage and apoptosis.

Q3: What cancers does Adriamycin specifically treat?

Adriamycin treats breast cancer (AC/FAC regimens), Hodgkin and non-Hodgkin lymphoma (CHOP/ABVD), soft tissue and bone sarcomas, acute lymphoblastic and myeloblastic leukemias, and bladder, lung, and ovarian solid tumors.

Q4: How is Adriamycin administered?

It is administered exclusively as an intravenous injection or infusion by trained oncology nurses in a hospital or clinic setting. It must never be given intramuscularly or subcutaneously due to severe tissue damage risk.

Q5: What is the treatment schedule for Adriamycin?

Dosing schedules vary by cancer type and regimen. Most protocols use cycles every 3 weeks. Lifetime cumulative dose is strictly limited to protect the heart. Your oncologist determines the precise schedule.

Q6: What are the most common side effects?

Common side effects include nausea, vomiting, hair loss (alopecia), mouth sores (mucositis), red-orange urine discoloration (not harmful), and bone marrow suppression causing low blood counts.

Q7: What is cardiotoxicity and why does it matter?

Doxorubicin can damage heart muscle cells, leading to cardiomyopathy and heart failure — especially with higher cumulative doses. Echocardiograms are performed before starting and periodically during treatment to monitor cardiac function.

Q8: What serious side effects require emergency care?

Seek immediate care for: fever with low neutrophil count (neutropenic fever), severe chest pain or shortness of breath (cardiac toxicity), burning pain during infusion (extravasation), or severe oral infections.

Q9: What drugs interact with Adriamycin?

Major interactions include trastuzumab (greatly increases cardiac risk), cyclosporine, and paclitaxel. All hepatic enzyme inducers or inhibitors and live vaccines should be discussed with your oncologist before administration.

Q10: Is Adriamycin safe during pregnancy?

No. Doxorubicin is embryotoxic and teratogenic — it can cause serious fetal harm. It should not be used during pregnancy unless the potential benefit justifies the risk. Effective contraception is required during treatment.

Q11: What monitoring is required during Adriamycin treatment?

Mandatory monitoring includes: cardiac function (LVEF by echocardiogram or MUGA scan), complete blood counts before each cycle, liver function tests, and cumulative dose tracking to prevent exceeding safe lifetime limits.

Q12: Is Adriamycin available without a prescription?

No. Adriamycin is a cytotoxic chemotherapy agent available exclusively through hospital oncology departments under strict specialist prescription and administration protocols.